Gene · 6357
Papers3,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Increased Nasal Fluids-Serum Concordance of Protein Profile with Prognosis in Nasal Polyps. | J Inflamm Res | 2026 | 41717500 | PubTator, text mining | PubMed |
| Extended treatment of abrocitinib: evaluation of efficacy and safety in chronic actinic dermatitis. | Front Med (Lausanne) | 2026 | 41716804 | PubTator, text mining | PubMed |
| Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer. | JCO Precis Oncol | 2026 | 41712875 | PubTator, text mining | PubMed |
| Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort. | Front Immunol | 2026 | 41705248 | PubTator, text mining | PubMed |
| Causal relationship between 91 inflammatory factors and fetal growth restriction: a bidirectional Mendelian randomization study. | J Matern Fetal Neonatal Med | 2026 | 41702666 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis and Machine Learning to Identify Biomarkers and Fibroblast-related Features of Idiopathic Pulmonary Fibrosis. | Curr Med Chem | 2026 | 41691678 | PubTator, text mining | PubMed |
| Inflammatory profile associated with hyperglycemia in children with type 1 diabetes. | J Diabetes Complications | 2026 | 41643243 | PubTator, text mining | PubMed |
| Correction: Immuno-transcriptomic analysis based on machine learning identifies immunity signature genes of chronic rhinosinusitis with nasal polyps. | Sci Rep | 2026 | 41639325 | PubTator, text mining | PubMed |
| Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma. | J Immunother Cancer | 2026 | 41617393 | PubTator, text mining | PubMed |
| Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers. | EJHaem | 2026 | 41613951 | PubTator, text mining | PubMed |
| Novel Therapeutic Strategies for Atopic Dermatitis: Biomarker Modulation and Clinical Implications. A Systematic Review. | Clin Rev Allergy Immunol | 2026 | 41609895 | PubTator, text mining | PubMed |
| Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle? | Clin Rev Allergy Immunol | 2026 | 41591698 | PubTator, text mining | PubMed |
| Central compartment atopic disease: Advances in pathogenesis and stratified treatment. | J Int Med Res | 2026 | 41575166 | PubTator, text mining | PubMed |
| Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer. | J Immunother Cancer | 2026 | 41571299 | PubTator, text mining | PubMed |
| Immunoprotective and neuroprotective properties of gut microbiome in psoriasis. | J Transl Autoimmun | 2026 | 41568321 | PubTator, text mining | PubMed |
| Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype. | Invest Ophthalmol Vis Sci | 2026 | 41563014 | PubTator, text mining | PubMed |
| Integrated Proteomic and Metabolomic Profiling for Developing Novel Plasma-Based Diagnostic Models of Sarcopenia. | J Cachexia Sarcopenia Muscle | 2026 | 41545024 | PubTator, text mining | PubMed |
| GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer. | Res Sq | 2026 | 41542041 | PubTator, text mining | PubMed |
| A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID. | Nat Immunol | 2026 | 41535626 | PubTator, text mining | PubMed |
| Characterising interleukin-27 (IL-27) responses in human blood derived macrophage cells. | Cytokine | 2026 | 41435503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6357/papers?page=4